Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1001–1020 of 17,529 recalls

November 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 1, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules

The Issue: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 1, 2024· JR Watkins

Recalled Item: Cooling Menthol Extra Strength Pain Relief Patch

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 31, 2024· Noven Pharmaceuticals Inc

Recalled Item: Xelstrym (dextroamphetamine) transdermal system

The Issue: Defective Delivery System: The product does not meet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 30, 2024· Baxter Healthcare Corporation

Recalled Item: Regadenoson Injection

The Issue: Labeling: Missing Label

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 29, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: IBU (ibuprofen) 600 mg tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
October 29, 2024· VIONA PHARMACEUTICALS INC

Recalled Item: Dapsone Gel 7.5%

The Issue: Crystallization

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 29, 2024· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP

The Issue: Defective Container: Unable to get the solution out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 25, 2024· Lannett Company Inc.

Recalled Item: Lisdexamfetamine Dimesylate Capsules

The Issue: Failed Content Uniformity Specifications: Product failed to meet

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: THERACARE Cold Hot Medicated Patch

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: ABSORBINE jr. Extra Large BACK PATCH

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: PARCHE LEON PAIN RELIEVING HOT PATCH

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: LILAS Feminine Pain Relief Patch

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: JR WATKINS COOLING PAIN RELIEF PATCHES

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: ABSORBINE jr ULTRA STRENGTH PAIN PATCH

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund